Brand Name: TRODELVY Generic Name: sacituzumab govitecan-hziy. It is used to treat adults with a type of breast cancer known as triple-negative breast cancer.
TRODELVY is a Trop-2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease.
| Brand Name: | TRODELVY |
| Generic Name: | sacituzumab govitecan-hziy |
| Strength: | • For injection: 180 mg lyophilized powder in single-dose vials for reconstitution. |
| Manufacturer: | Gilead Sciences, Inc. |
| Approved By: | EMA, USFDA |
Source content : www.accessdata.fda.gov
IPN, New Delhi can facilitate patient to import of “TRODELVY (sacituzumab govitecan-hziy) for injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.
